Publication | Closed Access

Design, synthesis and biological evaluation of N -((1-benzyl-1 H -1,2,3-triazol-4-yl)methyl)-1,3-diphenyl-1 H -pyrazole-4-carboxamides as CDK1/Cdc2 inhibitors

Medicinal ChemistryBiochemistryCdk1/cdc2 InhibitorsMedicineNatural SciencesRational Drug DesignPharmacological AgentPharmacotherapyAnti-cancer Agent-1,3-Diphenyl-1 HDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug DiscoveryH -1,2,3-Triazol-4-yl